Rep-HepG2 Cells
Cosmo Bio
- Catalog No.:
- PMC-REP-HEPG2C
- Shipping:
- Calculated at Checkout
$521.00
Additional documentation is required to purchase this product (e.g. permits or agreements). Review requirements before ordering. Click for details.
Related Products
Product Description
Human liver cells with high expression of drug-metabolizing enzymes.
Rep-HepG2 cells are derived from the HepG2 human hepatoma line, treated with a DNA methylation inhibitor to induce epigenetic changes. They are characterized by robust expression of drug-metabolizing enzymes, including CYP3A4, for both Phase I and Phase II reactions. These cells make a promising human hepatocyte model for basic and drug screening research.
These cells are easy to handle and can be used for experiments just 4-5 days after seeding the frozen cells. They also support long-term culture. Ideal for use in drug metabolism studies as an alternative to traditional HepG2 or human primary hepatocytes.
| Documents & Links for Rep-HepG2 Cells | |
| Datasheet | Rep-HepG2 cells Datasheet |
| Purchase Agreement | Direct Shipment and Fees Authorization |
| Documents & Links for Rep-HepG2 Cells | |
| Datasheet | Rep-HepG2 cells Datasheet |
| Purchase Agreement | Direct Shipment and Fees Authorization |
| Citations for Rep-HepG2 Cells – 0 Found |
Documentation Requirements for Order Placement
Direct Shipment and Fees Authorization
This item must ship directly from our Japan office due to permit requirements, temperature sensitivity, or other shipping considerations. Access the direct shipment authorization form in the Documents section above. Please download and fill in the document as requested. Submit the completed document with your order to orders@cosmobiousa.com.